Filing Details
- Accession Number:
- 0001209191-20-050693
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 16:22:31
- Reporting Period:
- 2020-09-10
- Accepted Time:
- 2020-09-16 16:22:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1626878 | Xbiotech Inc. | XBIT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1638762 | Sushma Shivaswamy | 3443 Shiraz Loop Round Rock TX 78665 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2020-09-10 | 19,332 | $7.50 | 19,332 | No | 4 | M | Direct | |
Common Shares | Disposition | 2020-09-10 | 19,332 | $20.01 | 0 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2020-09-15 | 20,668 | $7.50 | 20,668 | No | 4 | M | Direct | |
Common Shares | Disposition | 2020-09-15 | 20,668 | $20.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stocks | Stock options | Disposition | 2020-09-10 | 19,332 | $0.00 | 19,332 | $7.50 |
Common Stocks | Stock Options | Disposition | 2020-09-15 | 20,668 | $0.00 | 20,668 | $7.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-02-28 | 2021-02-28 | No | 4 | M | Direct |
0 | 2020-02-28 | 2021-02-28 | No | 4 | M | Direct |